Soleno Therapeutics

Yahoo Finance • 2 days ago

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting fro... Full story

Yahoo Finance • 2 days ago

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman

SAN FRANCISCO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by Scorpion Capital. Hagens Berman,... Full story

Yahoo Finance • 2 days ago

SOLENO (SLNO) REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Soleno and would like to discus... Full story

Yahoo Finance • 4 days ago

SLNO 投資者消息：若您因 Soleno Therapeutics, Inc. (NASDAQ: SLNO) 蒙受損失，請聯絡 Rosen Law Firm 了解您的權益

紐約, Oct. 08, 2025 (GLOBE NEWSWIRE) -- 事因：全球投資者權益律師事務所 Rosen Law Firm 繼續代表 Soleno Therapeutics, Inc. (NASDAQ: SLNO) 的股東，調查 Soleno Therapeutics 可能向投資公眾發佈重大誤導性業務資訊並就此引發的潛在證券索賠。 影響：若您購買了 Soleno Therapeutics 證券，您可能有權獲得賠償，並透過勝訴收費安排，免去任何自付費用或... Full story

Yahoo Finance • 4 days ago

Soleno rated as new Buy at Goldman Sachs on Vykat XR potential

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Soleno Therapeutics (SLNO) has been initiated with Buy at Goldman Sachs citing strong fundamentals and blockbuster potential for its lead asset, Vykat XR, in treating... Full story

Yahoo Finance • 16 days ago

SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Soleno and would like to discus... Full story

Yahoo Finance • 17 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 17 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • 23 days ago

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Soleno (SLNO) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Soleno and would like to discus... Full story

Yahoo Finance • 23 days ago

Soleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR Expands

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Soleno Therapeutics, Inc. is one of them. Soleno Therapeutics, Inc. (NASDAQ:SLNO) tops our list for being one of the most oversold stocks.... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Retreat Late Afternoon

Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index falling 0.8% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Noteworthy Wednesday Option Activity: VMEO, APLD, SLNO

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Vimeo Inc (Symbol: VMEO), where a total volume of 10,063 contracts has been traded thus far today, a contract volume whic... Full story

Yahoo Finance • last month

RSI Alert: Soleno Therapeutics (SLNO) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • last month

Bragar Eagel & Squire, P.C. Is Investigating Fortinet, Roblox, Soleno, and Simulations Plus and Encourages Investors to Contact the Firm

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fortinet, Inc. (NASDAQ:FTNT), Roblox Corporation (NYSE:RBLX), Soleno... Full story

Yahoo Finance • last month

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO).  Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • last month

Soleno Therapeutics to Participate in Upcoming September Conferences

REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will parti... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC

ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Soleno Therapeutics, Inc. (“Soleno Therapeutics” or the “Company”) (NASDAQ: SLNO) complied with federal securities laws. On August 15, 2025, Scorpio... Full story

Yahoo Finance • 2 months ago

Soleno Therapeutics stock maintains Buy rating at TD Cowen on strong sales momentum

Investing.com - TD Cowen has reiterated its Buy rating and $120.00 price target on Soleno Therapeutics Inc. (NASDAQ:SLNO) following the company’s second-quarter earnings report. The company, currently valued at $3.81 billion, has analyst t... Full story

Yahoo Finance • 2 months ago

Soleno Therapeutics plunges after short report from Scorpion Capital

[Sorting Medications] microgen/iStock via Getty Images Soleno Therapeutics (SLNO) dropped 16% in premarket trading after a new short report from Scorpion Capital. Scorpion Capital disclosed that it's short Soleno Therapeutics (NASDAQ:SLN... Full story

Yahoo Finance • 2 months ago

Soleno signals $500M cash war chest and robust Vykat XR launch trajectory while advancing EU expansion

Earnings Call Insights: Soleno Therapeutics (SLNO) Q2 2025 MANAGEMENT VIEW * CEO Anish Bhatnagar highlighted the commercial launch of Vykat XR and its approval as the first FDA-approved medicine for hyperphagia in adults and children 4... Full story